Engineered picornavirus VPg-RNA substrates: analysis of a tyrosyl-RNA phosphodiesterase activity.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3049768)

Published in PLoS One on March 07, 2011

Authors

Janet M Rozovics1, Richard Virgen-Slane, Bert L Semler

Author Affiliations

1: Department of Microbiology and Molecular Genetics, School of Medicine, University of California Irvine, Irvine, California, United States of America.

Articles cited by this

Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J Exp Med (1956) 22.68

Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61

Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. Proc Natl Acad Sci U S A (1977) 8.12

A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92

The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26

5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78

Aspects of the synthesis of poliovirus RNA and the formation of virus particles. Virology (1966) 5.85

The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61

O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68

In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54

Protein is linked to the 5' end of poliovirus RNA by a phosphodiester linkage to tyrosine. J Biol Chem (1978) 4.17

Cascade control of Escherichia coli glutamine synthetase. Properties of the PII regulatory protein and the uridylyltransferase-uridylyl-removing enzyme. J Biol Chem (1975) 4.00

The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97

Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature (1998) 3.64

Structural difference between the 5' termini of viral and cellular mRNA in poliovirus-infected cells: possible basis for the inhibition of host protein synthesis. J Virol (1976) 3.46

Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science (1999) 3.29

Genome-linked proteins of viruses. Cell (1982) 3.02

5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00

A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A (1996) 2.96

Coupling between genome translation and replication in an RNA virus. Genes Dev (1994) 2.82

Identification of a protein linked to nascent poliovirus RNA and to the polyuridylic acid of negative-strand RNA. J Virol (1978) 2.54

Cytotoxicity of a factor isolated from human spleen. J Natl Cancer Inst (1973) 2.38

Functional coupling between replication and packaging of poliovirus replicon RNA. J Virol (1999) 2.38

A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature (2009) 2.33

The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A (2001) 2.18

Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14

Chromosomal aberrations in human neuroblastomas. Cancer (1977) 2.01

Conservation of RNA-protein interactions among picornaviruses. J Virol (1992) 1.81

The fate of VPg during in vitro translation of poliovirus RNA. FEBS Lett (1981) 1.74

Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication. J Virol (2002) 1.71

An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5' terminal protein. Cell (1978) 1.69

Mutational analysis of the genome-linked protein VPg of poliovirus. J Virol (1988) 1.66

Construction of a "mutagenesis cartridge" for poliovirus genome-linked viral protein: isolation and characterization of viable and nonviable mutants. Proc Natl Acad Sci U S A (1988) 1.61

Purification and properties of a HeLa cell enzyme able to remove the 5'-terminal protein from poliovirus RNA. J Biol Chem (1980) 1.28

Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol (1996) 1.26

The formation of poliovirus particles in association with the RNA replication complexes. J Gen Virol (1973) 1.23

Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol Ther (1989) 1.22

5' termini of poliovirus RNA: difference between virion and nonencapsidated 35S RNA. J Virol (1977) 1.21

Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog (2010) 1.20

Persistent infection of human erythroblastoid cells by poliovirus. Virology (1993) 1.16

Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells. Virology (1992) 1.13

Protein-linked RNA of poliovirus is competent to form an initiation complex of translation in vitro. Nature (1980) 1.13

Transient kinetics of formation and reaction of the uridylyl-enzyme form of galactose-1-P uridylyltransferase and its Q168R-variant: insight into the molecular basis of galactosemia. Biochemistry (1998) 1.06

Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate. J Virol (1981) 0.97

Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins. Virology (2010) 0.94

Viability of poliovirus/rhinovirus VPg chimeric viruses and identification of an amino acid residue in the VPg gene critical for viral RNA replication. J Virol (2003) 0.89

Cytoplasmic inheritance of erythromycin resistance in human cells. Proc Natl Acad Sci U S A (1979) 0.86

Galactose-1-phosphate uridylyltransferase. Purification of the enzyme and stereochemical course of each step of the double-displacement mechanism. Biochemistry (1986) 0.84

An enzyme which specifically splits a covalent bond between picornaviral RNA and VPg. FEBS Lett (1988) 0.83

VPg unlinkase, the phosphodiesterase that hydrolyzes the bond between VPg and picornavirus RNA: a minimal nucleic moiety of the substrate. Biochemistry (Mosc) (2002) 0.82

Natural covalent complexes of nucleic acids and proteins: some comments on practice and theoryon the path from well-known complexes to new ones. Nucleic Acids Res (1998) 0.81

[Natural substrates of uridylylpolynucleotide-(5'P--->O)-tyrosine phosphodiesterase--an enzyme, hydrolyzing the covalent bond between RNA and picornaviral VPg and a synthetic model of them]. Biokhimiia (1996) 0.78

[Characteristics of an enzyme hydrolyzing the covalent bond between RNA and protein VPg of the encephalomyocarditis virus]. Biokhimiia (1986) 0.77

Articles by these authors

Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication. J Virol (2002) 1.71

A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation. EMBO J (2006) 1.71

Regulation of picornavirus gene expression. Microbes Infect (2004) 1.66

Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochim Biophys Acta (2009) 1.62

Cellular protein modification by poliovirus: the two faces of poly(rC)-binding protein. J Virol (2007) 1.51

Functional interaction of heterogeneous nuclear ribonucleoprotein C with poliovirus RNA synthesis initiation complexes. J Virol (2005) 1.48

Stress-inducible alternative translation initiation of human cytomegalovirus latency protein pUL138. J Virol (2010) 1.29

MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep (2012) 1.22

Atomic force microscopy analysis of icosahedral virus RNA. J Mol Biol (2005) 1.21

Multimerization of poly(rC) binding protein 2 is required for translation initiation mediated by a viral IRES. RNA (2004) 1.21

SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog (2011) 1.17

Allosteric effects of ligands and mutations on poliovirus RNA-dependent RNA polymerase. J Virol (2005) 1.11

An RNA virus hijacks an incognito function of a DNA repair enzyme. Proc Natl Acad Sci U S A (2012) 1.08

Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis. J Virol (2004) 1.07

An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA (2005) 1.07

Re-localization of cellular protein SRp20 during poliovirus infection: bridging a viral IRES to the host cell translation apparatus. PLoS Pathog (2011) 1.04

Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity. Virology (2009) 1.01

The linker domain of poly(rC) binding protein 2 is a major determinant in poliovirus cap-independent translation. Virology (2008) 1.01

An authentic 3' noncoding region is necessary for efficient poliovirus replication. J Virol (2005) 0.99

Picornavirus modification of a host mRNA decay protein. MBio (2012) 0.98

Subdomain specific functions of the RNA polymerase region of poliovirus 3CD polypeptide. Virology (2002) 0.98

Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. J Virol (2013) 0.96

Structurally distinct elements mediate internal ribosome entry within the 5'-noncoding region of a voltage-gated potassium channel mRNA. J Biol Chem (2004) 0.95

Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins. Virology (2010) 0.94

Viral subversion of host functions for picornavirus translation and RNA replication. Future Virol (2012) 0.93

Alphacoronavirus transmissible gastroenteritis virus nsp1 protein suppresses protein translation in mammalian cells and in cell-free HeLa cell extracts but not in rabbit reticulocyte lysate. J Virol (2010) 0.92

Mechanistic consequences of hnRNP C binding to both RNA termini of poliovirus negative-strand RNA intermediates. J Virol (2010) 0.91

Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections. J Virol (2012) 0.87

Mechanistic intersections between picornavirus translation and RNA replication. Adv Virus Res (2011) 0.85

Strand-specific RNA synthesis determinants in the RNA-dependent RNA polymerase of poliovirus. J Virol (2004) 0.84

Functional conservation of the hydrophobic domain of polypeptide 3AB between human rhinovirus and poliovirus. Virology (2003) 0.84

Inhibition of poliovirus-induced cleavage of cellular protein PCBP2 reduces the levels of viral RNA replication. J Virol (2013) 0.82

Poliovirus infection induces the co-localization of cellular protein SRp20 with TIA-1, a cytoplasmic stress granule protein. Virus Res (2013) 0.82

Modification of picornavirus genomic RNA using 'click' chemistry shows that unlinking of the VPg peptide is dispensable for translation and replication of the incoming viral RNA. Nucleic Acids Res (2013) 0.82

Differential rescue of poliovirus RNA replication functions by genetically modified RNA polymerase precursors. J Virol (2004) 0.82

Alternative polyadenylation signals in the 3' non-coding region of a voltage-gated potassium channel gene are major determinants of mRNA isoform expression. Gene (2007) 0.76

Resistance is futile. Nat Genet (2005) 0.75

In memoriam John J. Holland (1929-2013): a pioneer in molecular virology. J Virol (2014) 0.75

Methods to study RNA virus molecular biology. Methods (2013) 0.75